BankM starts Bio-Gate coverage with Buy, price target EUR 6.78-8.3

PUBT · 2d ago
BankM starts Bio-Gate coverage with Buy, price target EUR 6.78-8.3
  • BankM initiated coverage of Bio-Gate with a Buy rating on July 27, 2026.
  • Set a 12-month price target range of EUR 6.78 to EUR 8.30, stated on a pro forma basis for capital measures.
  • Research cited Bio-Gate’s silver-based antimicrobial coating technology for medical devices as a key investment driver.
  • Report noted a capital increase has been decided.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bio-Gate AG published the original content used to generate this news brief via EQS News (Ref. ID: rc_26294) on July 27, 2026, and is solely responsible for the information contained therein.